Review
Copyright ©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 566-600
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.566
Table 15 Effects and molecular mechanisms underlying nanoclay, NCD, polystyrene, chytosan induced hepatonanotoxicity
NPs
Size
Tested model
Dose & route of administration
Effects & mechanism
Ref.
Nano-Clay57.8 ± 12.3 nm & 648.3 ± 232.2 nmBALB/C mice1, 5, 10, 20 mg/kg b.w. (Iv) 24 h; Co-administered with Ccl4, paraquat, cisplatinALT, AST (increased)[163]
NCD (modified nanocellulose with oxalate esters)100 nm (SEM)Wistar rat50 & 100 mg/kg b.w. (oral) for 7 dALT, AST (increased); CAT, GPx activity (decreased); MPO activity (increased); iNOS, Bax (increased); dialated sinusoidal space, vacuolated hepatocytes, cellular infiltration[29]
Oxidative stress
PolystyrenePS NPs 158.8 ± 1.3 nm; aPS NPs 117.0 ± 1.8 nm (SEM)ICR mice50 mg/kg/d (oral) for 7 dGlucose, HDL-C, TG, TC (increased in blood); LDL-C (decreased in blood); Activation of PI3K/AKT/GLUT4 & SREBP-1/PPARγ/ATGL signaling pathways; TG decomposition; Lipid accumulation (increased); Nuclear pyknosis, blurred intercellular space, central hepatic vein congestion, hepatic ballooning; Compared to PS NPs, aPS NPs showed higher toxicity[28]
Disruption of glycolipid metabolism
Chitosan (CsNPs)18 ± 1 nm (DLS)BHAL cell≥ 0.5% w/v for 4 hReadily internalized; Disrupt membrane integrity; ALT leakage; CYP3A4 enzyme activity (increased); necrotic or autophagic cell death[27]